Discontinued — last reported Q4 '25
Total Revenue
Over 4 years (FY 2021 to FY 2025), Total Revenue shows a downward trend with a -100.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.70M | $1.10M | $9.46M | $7.58M | $9.12M | $3.36M | $15.33M | $7.01M | $3.82M | $0.00 | $742.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -87.3% | +759.2% | -19.9% | +20.3% | -63.2% | +356.8% | -54.2% | -45.5% | -100.0% | — | -100.0% | — | — | — | — | — | — | — |
| YoY Change | — | — | — | — | +4.8% | +204.8% | +62.1% | -7.4% | -58.1% | -100.0% | -95.2% | -100.0% | -100.0% | — | -100.0% | — | — | — | — |
Product Breakdown
| Segment | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 |
|---|---|---|---|---|---|---|---|
| Collaboration Revenue | $8.70M | $1.10M | $9.46M | $7.58M | $9.12M | $3.36M | $7.01M |
| Total | $8.70M | $1.10M | $9.46M | $7.58M | $9.12M | $3.36M | $7.01M |
Collaboration Revenue was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Revenue at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s total revenue?
- Revolution Medicines, Inc. (RVMD) reported total revenue of $0.00 in Q4 2025.
- What is the long-term trend for Revolution Medicines, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $29.39M to $0.00.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.